Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Poly(2-oxazoline) production

Outputs and Outcomes

Acronym

PAOx plant

Code

F2014/IOF-STEPST/215

Duration

15 January 2015 → 31 December 2017

Funding

Regional and community funding: Industrial Research Fund

Promotor

Thomas De Beer

Research disciplines

Medical and health sciences
- Biomarker discovery and evaluation
- Drug discovery and development
- Medicinal products
- Pharmaceutics
- Pharmacognosy and phytochemistry
- Pharmacology
- Pharmacotherapy
- Toxicology and toxinology
- Other pharmaceutical sciences

Keywords

Poly(2-oxazoline)

Project description

This Stepstone project will provide us with the sufficient timeframe and resources to scale-up PAOx production and to prepare the business-model, leading to successful validation and robust commercialization of high-quality, highly defined functional PAOx under the tradename Ultroxa®.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by